Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. LEROY F; GODIN M; LEGALLICLER B; FILLASTRE JP; BIDAULT R; POSNER J; PECK RW
   PHARMACOKINETICS OF NETIVUDINE IN HEMODIALYSIS-PATIENTS
   Journal of antimicrobial chemotherapy
   
   F. Leroy et al., "PHARMACOKINETICS OF NETIVUDINE IN HEMODIALYSIS-PATIENTS", Journal of antimicrobial chemotherapy, 38(5), 1996, pp. 913-915
2. PECK RW; WOOTTON R; LEE DR; JACKSON SHD; POSNER J
   THE BIOAVAILABILITY AND DISPOSITION OF 1-(BETA-D-ARABINOFURANOSYL)-5-(1-PROPYNYL)URACIL (882C87), A POTENT, NEW ANTI-VARICELLA ZOSTER VIRUSAGENT
   British journal of clinical pharmacology
   
   R.W. Peck et al., "THE BIOAVAILABILITY AND DISPOSITION OF 1-(BETA-D-ARABINOFURANOSYL)-5-(1-PROPYNYL)URACIL (882C87), A POTENT, NEW ANTI-VARICELLA ZOSTER VIRUSAGENT", British journal of clinical pharmacology, 39(2), 1995, pp. 143-149
3. DARBY G
   THE ACYCLOVIR LEGACY - ITS CONTRIBUTION TO ANTIVIRAL DRUG DISCOVERY
   Journal of medical virology
   
   G. Darby, "THE ACYCLOVIR LEGACY - ITS CONTRIBUTION TO ANTIVIRAL DRUG DISCOVERY", Journal of medical virology, 1993, pp. 134-138